MLYS - CIK 0001933414
Mineralys Therapeutics, Inc. (MLYS) reported net income of -$154.65M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | -$154.65M | +13.0% |
| FY 2024 | -$177.81M | -147.3% |
| FY 2023 | -$71.90M | -141.3% |
| FY 2022 | -$29.80M | - |
Mineralys Therapeutics, Inc. (MLYS) reported net income of -$154.65M for fiscal year 2025, as filed in its audited annual report with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.